GlassScriptPhysician profile
Jeffrey N Moore
NPI 1649202375
$917.20
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $290 · 2021: $23.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $273.45 | 2019-2021 | |
| Misonix INC | $257.00 | 2019 | |
| Osiris Therapeutics INC. | $127.22 | 2019 | |
| Organogenesis INC. | $121.59 | 2019-2020 | |
| Kci USA, INC. | $34.93 | 2019-2020 | |
| Melinta Therapeutics, LLC | $34.30 | 2020 | |
| Allergan, INC. | $32.30 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $19.29 | 2019 | |
| Medline Industries LP | $17.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.